Workflow
CEO(688335)
icon
Search documents
1月29日晚间重要公告一览
Xi Niu Cai Jing· 2026-01-29 10:13
Earnings Forecasts - Shengyi Electronics expects a net profit of 1.431 billion to 1.513 billion yuan in 2025, an increase of 331.03% to 355.88% year-on-year [1] - Tigermed anticipates a net profit of 830 million to 1.23 billion yuan in 2025, representing a growth of 105% to 204% year-on-year [2] - Shunbo Alloy forecasts a net profit of 210 million to 270 million yuan in 2025, with an increase of 222.96% to 315.23% year-on-year [3] - Jinkong Electric expects a net profit of 155 million to 195 million yuan in 2025, reflecting a growth of 383.21% to 507.9% year-on-year [9] - Baiao Saitu anticipates a net profit of 162 million to 182 million yuan in 2025, with a year-on-year increase of 384.26% to 443.88% [18] - Panjiang Co. expects a net profit of 318 million to 380 million yuan in 2025, representing a growth of 205.30% to 264.83% year-on-year [38] Loss Forecasts - Liaoning Energy predicts a net loss of 273 million to 410 million yuan in 2025, compared to a profit of 202 million yuan in the previous year [5] - Anbotong anticipates a net loss of 114 million to 165 million yuan in 2025, with a revenue decrease of 19.65% to 27.25% [7] - Wantai Bio forecasts a net loss of 330 million to 410 million yuan in 2025, compared to a profit of 106 million yuan in the previous year [12] - Xingyun Co. expects a net loss of 155 million to 230 million yuan in 2025, compared to a loss of 82.44 million yuan in the previous year [20] - Huaxing Co. anticipates a net loss of 800 million to 1.2 billion yuan in 2025, with a reduction in loss compared to 1.67 billion yuan in the previous year [46] New Product Approvals - Hengrui Medicine received acceptance for a new indication application for its innovative drug, combining Carrelizumab and Apatinib for treating unresectable liver cancer [4] - Tianen Kang's subsidiary received a drug registration acceptance notice for Lidocaine and Prilocaine aerosol [31] - Lisheng Pharmaceutical announced that its Aminophylline tablets passed the consistency evaluation for generic drugs [40] Share Buyback Plans - Hengyuan Coal Power plans to repurchase shares with a total amount not less than 200 million yuan and not exceeding 250 million yuan [13] Contract Wins - China Communication Signal Co. won contracts totaling approximately 5.26 billion yuan for 21 important projects in the railway and urban rail transit markets [37]
复洁科技(688335.SH):预计2025年净利润1100万元左右
Ge Long Hui A P P· 2026-01-29 08:41
在行业整体面临宏观市场环境变化及竞争加剧的背景下,公司营业收入虽实现同比增长,但受市场竞争 及毛利率下行等因素影响,预计2025年年度实现归属于母公司所有者扣除非经常性损益后的净利润为 负。 格隆汇1月29日丨复洁科技(688335.SH)公布,公司财务部门初步测算,预计2025年年度公司实现归属于 母公司所有者的净利润与上年同期(法定披露数据)相比,将实现扭亏为盈,实现归属于母公司所有者 的净利润1,100.00万元左右。预计2025年年度公司实现归属于母公司所有者扣除非经常性损益后的净利 润-760.00万元左右。 ...
复洁科技:2025年全年净利润预计约为1100.00万元左右,同比扭亏
南财智讯1月29日电,复洁科技发布年度业绩预告,预计2025年全年归属于上市公司股东的净利润为 1100.00万元左右,预计同比扭亏;预计2025年全年归属于上市公司股东的扣除非经常性损益的净利润 为-760.00万元左右。本期业绩变化的主要原因:(一)2025年,公司锚定主责主业战略方向,凭借长 期积累的竞争优势和优质的客户资源,积极优化业务结构与产品矩阵,以优质项目为主线持续深耕细 作,稳步推进在手项目实施,营业收入实现同比增长;同时,公司积极贯彻落实"提质增效重回报"行动 方案,通过采取降本增效、费用管控等举措,期间费用实现同比下降;报告期内,公司非经常性损益实 现同比增长,主要包括因前沿科研活动取得财政资金拨付、通过提高现金管理效率获得投资收益以及或 有事项冲回部分预计负债等。上述因素对本期利润构成正向影响,预计2025年年度实现归属于母公司所 有者的净利润与上年同期(法定披露数据)相比,将实现扭亏为盈。(二)在行业整体面临宏观市场环 境变化及竞争加剧的背景下,公司营业收入虽实现同比增长,但受市场竞争及毛利率下行等因素影响, 预计2025年年度实现归属于母公司所有者扣除非经常性损益后的净利润为负。 ...
复洁科技(688335) - 2025 Q4 - 年度业绩预告
2026-01-29 08:20
(一)业绩预告期间 2025年1月1日至2025年12月31日。 (二)业绩预告情况: 证券代码:688335 证券简称:复洁科技 公告编号:2026-003 上海复洁科技股份有限公司 2025年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、本期业绩预告情况 (二)在行业整体面临宏观市场环境变化及竞争加剧的背景下,公司营业收 入虽实现同比增长,但受市场竞争及毛利率下行等因素影响,预计2025年年度实 现归属于母公司所有者扣除非经常性损益后的净利润为负。 1.经上海复洁科技股份有限公司(以下简称"公司")财务部门初步测算, 预计2025年年度公司实现归属于母公司所有者的净利润与上年同期(法定披露数 据)相比,将实现扭亏为盈,实现归属于母公司所有者的净利润1,100.00万元左 右。 2.预计2025年年度公司实现归属于母公司所有者扣除非经常性损益后的净利 润-760.00万元左右。 (三)公司本次业绩预告未经注册会计师审计。 二、上年同期业绩情况和财务状况 (一)利润总额:-6,072.84万元;归属于母 ...
复洁科技实控人方拟套现约5500万元 扣非连亏1年3季
Zhong Guo Jing Ji Wang· 2026-01-28 06:00
黄文俊、孙卫东、许太明、吴岩及上海众洁投资管理合伙企业(有限合伙)(简称"众洁投资")计划自公告披露之日起15个交 易日后的3个月内(即2026年2月27日-2026年5月26日)通过集中竞价方式分别减持其所持有的公司股份数量不超过296,069股,分 别减持的股份数量均不超过公司总股本的0.20%,合计减持的股份数量不超过1,480,345股(即不超过公司总股本的1.00%)。 根据复洁科技1月27日收盘价37.00元计算,本次减持套现金额约合5477.28万元。 截至公告披露日,公司实际控制人之一、董事长黄文俊直接持有公司股份24,400,047股,占公司总股本的16.48%,其中 24,345,596股为公司首次公开发行前取得的股份及资本公积金转增股本取得的股份,该部分已于2024年2月19日解除限售并上市流 通。其余股份,其中48,627股为集中竞价交易取得的股份及资本公积金转增股本取得的股份,5,824股为2023年限制性股票激励计 划归属取得。 公司实际控制人之一、董事孙卫东直接持有公司股份5,236,857股,占公司总股本的3.54%,其中5,170,844股为公司首次公开发 行前取得的股份及资 ...
复洁科技(688335.SH):沼气制绿色甲醇千吨级中试验证正在有序推进实施中
Ge Long Hui· 2026-01-28 00:53
格隆汇1月28日丨复洁科技(688335.SH)近日接受特定对象调研时表示,公司作为牵头承担单位,与上海 市科学技术委员会正式签署《战略前沿专项项目任务合同书》,联合华东理工大学、同济大学、上海交 通大学、上海城投老港实业发展有限公司、上海环境集团股份有限公司、中石化上海工程有限公司、上 港集团能源(上海)有限公司,共同开展"沼气全碳定向转化制绿色甲醇关键技术与中试验证"专项科研项 目。目前,公司已与联合参研单位持续开展项目的技术创新、工艺开发与试验验证工作,其中沼气制绿 色甲醇千吨级中试验证正在有序推进实施中。 ...
1月28日A股投资避雷针︱ST纳川:公司股票交易可能被实施退市风险警示;高盟新材:实际控制人、副董事长熊海涛被留置
Ge Long Hui· 2026-01-28 00:07
Shareholder Reductions - Zhishang Technology's shareholders Liu Dongsheng and Liu Dongli plan to reduce their holdings by no more than 3% [1] - Hengtian Hailong's shareholder Hengtian Group intends to reduce its holdings by no more than 3% [1] - Shouchuang Securities' shareholder Chengshi Dongli plans to reduce its holdings by no more than 27.245 million A-shares [1] - Olin Bio's shareholder Taichang Group intends to reduce its holdings by no more than 6 million shares [1] - Juhe Materials' shareholder Changzhou Pengji plans to reduce its holdings by no more than 1.2297% [1] - Fuzhijie Technology's actual controller and its concerted actors plan to reduce their holdings by no more than 1% [1] - Sanjiang Shopping's shareholder Alizetai has reduced 6.1653 million shares through block trading [1] - Aonong Bio's shareholders including Foreign Trade Trust, Xiamen Trust, and Beijing Yawen plan to reduce their holdings by no more than 1% [1] - Dongfang Communication has cumulatively reduced 2.6 million shares of Changxin Bochuang [1] - XG Group has cumulatively reduced 473,900 shares [1] - Jiazhe New Energy's GLP has cumulatively reduced 1.08% of the company's shares [1] - Tuojing Technology's shareholder National Integrated Circuit Fund has cumulatively reduced 2.99% of its shares through block trading [1] - Huizhiwei's shareholder Great Fund Phase II has cumulatively reduced 0.57542% of the company's shares [1] Other Notable Events - ST Nachuan's stock trading may be subject to delisting risk warning [1] - Gao Meng New Materials' actual controller and vice chairman Xiong Haitao has been detained [1]
股海导航_2026年1月28日_沪深股市公告与交易提示
Xin Lang Cai Jing· 2026-01-27 23:14
Group 1 - Heng Rui Medicine's HRS-5346 tablets have been included in the list of breakthrough therapeutic varieties by the National Medical Products Administration, with a total R&D investment of approximately 76.3 million yuan [30][30] - Yuguang Jin Lead announced a significant short-term stock price increase of 45.01% over five consecutive trading days, raising concerns about the uncertainty of future silver prices [31] - Dongcai Technology's actual controller and vice chairman has been detained and investigated, but the company states that this will not significantly impact its normal operations [32] Group 2 - Aisen Co. plans to invest 2 billion yuan to establish an integrated circuit materials manufacturing base in East China, with the first phase expected to be operational by 2028 [33] - Jingpin Special Equipment has been banned from participating in procurement activities for the armed police force for three years, which will have a limited impact on its overall revenue [34] - Nanhua Futures' overseas subsidiary has obtained membership approval for the Nodal Exchange, allowing it to trade and clear related products [35] Group 3 - Zhong Rare Earth expects a net profit of 100 million to 130 million yuan in 2025, reversing a loss of 299 million yuan in the previous year due to market recovery and operational improvements [38] - Deep South Circuit anticipates a net profit increase of 68% to 78% in 2025, driven by growth in AI computing power and storage market demand [39] - Hai Xin Energy Science and Technology expects a net loss of 450 million to 640 million yuan in 2025, although this is an improvement from a loss of 954 million yuan the previous year [40] Group 4 - Nanya New Materials forecasts a net profit increase of 337% to 417% in 2025, attributed to the recovery in the copper-clad laminate industry [41] - CanSino Biologics expects a net profit of 24.5 million to 29 million yuan in 2025, driven by the growth of its quadrivalent meningococcal vaccine [42] - Zhiguang Electric anticipates a net profit of 110 million to 160 million yuan in 2025, reversing a loss of 326 million yuan due to rapid growth in its energy storage business [43] Group 5 - Dongfang Securities expects a net profit increase of 67.8% in 2025, supported by growth in its core investment banking and wealth management businesses [44] - King Long Motors forecasts a net profit of approximately 463.26 million yuan in 2025, reflecting a 193.68% increase due to steady growth in overseas markets [45] - Zhenray Technology expects a net profit increase of 529.64% to 642.26% in 2025, driven by demand in special integrated circuits and satellite communication markets [46] Group 6 - Yongding Co. anticipates a net profit of 200 million to 300 million yuan in 2025, representing an increase of 225.66% to 388.48% due to investment income from its joint ventures [47] - Xiamen Tungsten's preliminary report indicates a net profit of 2.311 billion yuan in 2025, a 35.08% increase driven by rising prices of tungsten and rare earth materials [48] - Guodun Quantum expects to achieve a net profit of around 5 million yuan in 2025, reversing a loss from the previous year due to growth in the quantum computing sector [49] Group 7 - Shijia Photon anticipates a net profit of approximately 342 million yuan in 2025, reflecting a growth of around 426% due to increased orders in optical chips and cables [50] - Ningbo Fubang expects a net profit of 50 million to 70 million yuan in 2025, with a significant increase of 3099.59% to 4379.43% driven by rising silver prices and non-recurring gains [51] - Huasheng Lithium Battery plans to adjust its share repurchase price limit from 32 yuan to 150 yuan per share, reflecting confidence in its future development [52]
上海复洁科技股份有限公司实际控制人及其一致行动人减持股份计划公告
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:688335 证券简称:复洁科技 公告编号:2026-002 上海复洁科技股份有限公司实际控制人及其一致行动人减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏, 并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: ● 实际控制人及其一致行动人持股的基本情况 截至本公告披露日,上海复洁科技股份有限公司(以下简称"公司")实际控制人之一、董事长黄文俊先 生直接持有公司股份24,400,047股,占公司总股本的16.48%,其中24,345,596股为公司首次公开发行前 取得的股份及资本公积金转增股本取得的股份,该部分已于2024年2月19日解除限售并上市流通。其余 股份,其中48,627股为集中竞价交易取得的股份及资本公积金转增股本取得的股份,5,824股为2023年限 制性股票激励计划归属取得。 公司实际控制人之一、董事孙卫东先生直接持有公司股份5,236,857股,占公司总股本的3.54%,其中 5,170,844股为公司首次公开发行前取得的股份及资本公积金转增股本取得的股份 ...
复洁科技:实际控制人及其一致行动人减持股份计划公告
Zheng Quan Ri Bao· 2026-01-27 13:41
Core Viewpoint - The company, Fuzhijie Technology, announced a plan for share reduction by its actual controllers and associated parties, indicating a strategic move in their equity management [2] Group 1: Share Reduction Plan - The actual controllers, including Huang Wenjun, Sun Weidong, Xu Taiming, Wu Yan, and the associated party Zhongjie Investment, plan to reduce their holdings from February 27, 2026, to May 26, 2026 [2] - The total number of shares to be reduced is up to 1,480,345 shares, which represents 1.00% of the total share capital [2] - The shares to be reduced are sourced from pre-IPO holdings and capital reserve fund conversion into shares [2]